APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polio Vaccine

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

Selected research

Market Analysis & Forecast

Global Polio Vaccine Market Analysis and Forecast 2026-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchPolio Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Polio Vaccine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Polio Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polio Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Polio Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.

Read the full market overview

This report presents an overview of global market for Polio Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Polio Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Polio Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Polio Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Polio Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Polio Vaccine sales, projected growth trends, production technology, application and end-user industry.

Polio Vaccine Segment by Company

Sanofi

GSK

Bibcol

Serum Institute

Tiantan Biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Polio Vaccine Segment by Type

Inactivated Polio Vaccine (IPV)

Oral Polio Vaccine (OPV)

Polio Vaccine Segment by Application

Public

Private

Polio Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Polio Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polio Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Polio Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Inactivated Polio Vaccine (IPV) Major Manufacturers Table 3. Oral Polio Vaccine (OPV) Major Manufacturers Table 4. Global Polio Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Public Major Manufacturers Table 6. Private Major Manufacturers Table 7. Polio Vaccine Industry Trends Table 8. Polio Vaccine Industry Drivers Table 9. Polio Vaccine Industry Opportunities and Challenges Table 10. Polio Vaccine Industry Restraints Table 11. Global Polio Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Polio Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Polio Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Polio Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Polio Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Polio Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 17. Global Polio Vaccine Sales by Region (2021-2026) & (M Doses) Table 18. Global Polio Vaccine Sales by Region (2027-2032) & (M Doses) Table 19. Global Polio Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Polio Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Polio Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Polio Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Polio Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Polio Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Polio Vaccine Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 26. Global Polio Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Polio Vaccine Manufacturers, Product Type & Application Table 29. Global Polio Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Polio Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Polio Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Polio Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Polio Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Polio Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Polio Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Polio Vaccine Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 38. Global Polio Vaccine Sales by Type (2021-2026) & (M Doses) Table 39. Global Polio Vaccine Sales by Type (2027-2032) & (M Doses) Table 40. Global Polio Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Polio Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Polio Vaccine Price by Type (2021-2026) & (USD/K Doses) Table 43. Global Polio Vaccine Price by Type (2027-2032) & (USD/K Doses) Table 44. Global Polio Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Polio Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Polio Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Polio Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Polio Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Polio Vaccine Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 50. Global Polio Vaccine Sales by Application (2021-2026) & (M Doses) Table 51. Global Polio Vaccine Sales by Application (2027-2032) & (M Doses) Table 52. Global Polio Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Polio Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Polio Vaccine Price by Application (2021-2026) & (USD/K Doses) Table 55. Global Polio Vaccine Price by Application (2027-2032) & (USD/K Doses) Table 56. Sanofi Company Information Table 57. Sanofi Business Overview Table 58. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 59. Sanofi Polio Vaccine Product Portfolio Table 60. Sanofi Recent Development Table 61. GSK Company Information Table 62. GSK Business Overview Table 63. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 64. GSK Polio Vaccine Product Portfolio Table 65. GSK Recent Development Table 66. Bibcol Company Information Table 67. Bibcol Business Overview Table 68. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 69. Bibcol Polio Vaccine Product Portfolio Table 70. Bibcol Recent Development Table 71. Serum Institute Company Information Table 72. Serum Institute Business Overview Table 73. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 74. Serum Institute Polio Vaccine Product Portfolio Table 75. Serum Institute Recent Development Table 76. Tiantan Biological Company Information Table 77. Tiantan Biological Business Overview Table 78. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 79. Tiantan Biological Polio Vaccine Product Portfolio Table 80. Tiantan Biological Recent Development Table 81. IMBCA Company Information Table 82. IMBCA Business Overview Table 83. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 84. IMBCA Polio Vaccine Product Portfolio Table 85. IMBCA Recent Development Table 86. Panacea Biotec Ltd Company Information Table 87. Panacea Biotec Ltd Business Overview Table 88. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 89. Panacea Biotec Ltd Polio Vaccine Product Portfolio Table 90. Panacea Biotec Ltd Recent Development Table 91. Bio-Med Company Information Table 92. Bio-Med Business Overview Table 93. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 94. Bio-Med Polio Vaccine Product Portfolio Table 95. Bio-Med Recent Development Table 96. Halfkin Bio-Pharmaceuticals Company Information Table 97. Halfkin Bio-Pharmaceuticals Business Overview Table 98. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 99. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio Table 100. Halfkin Bio-Pharmaceuticals Recent Development Table 101. North America Polio Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Polio Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Polio Vaccine Sales by Type (2021-2026) & (M Doses) Table 104. North America Polio Vaccine Sales by Type (2027-2032) & (M Doses) Table 105. North America Polio Vaccine Sales Price by Type (2021-2026) & (USD/K Doses) Table 106. North America Polio Vaccine Sales Price by Type (2027-2032) & (USD/K Doses) Table 107. North America Polio Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Polio Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Polio Vaccine Sales by Application (2021-2026) & (M Doses) Table 110. North America Polio Vaccine Sales by Application (2027-2032) & (M Doses) Table 111. North America Polio Vaccine Sales Price by Application (2021-2026) & (USD/K Doses) Table 112. North America Polio Vaccine Sales Price by Application (2027-2032) & (USD/K Doses) Table 113. North America Polio Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Polio Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Polio Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Polio Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 117. North America Polio Vaccine Sales by Country (2021-2026) & (M Doses) Table 118. North America Polio Vaccine Sales by Country (2027-2032) & (M Doses) Table 119. North America Polio Vaccine Sales Price by Country (2021-2026) & (USD/K Doses) Table 120. North America Polio Vaccine Sales Price by Country (2027-2032) & (USD/K Doses) Table 121. United States Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 122. Canada Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 123. Mexico Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 124. Europe Polio Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Polio Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Polio Vaccine Sales by Type (2021-2026) & (M Doses) Table 127. Europe Polio Vaccine Sales by Type (2027-2032) & (M Doses) Table 128. Europe Polio Vaccine Sales Price by Type (2021-2026) & (USD/K Doses) Table 129. Europe Polio Vaccine Sales Price by Type (2027-2032) & (USD/K Doses) Table 130. Europe Polio Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Polio Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Polio Vaccine Sales by Application (2021-2026) & (M Doses) Table 133. Europe Polio Vaccine Sales by Application (2027-2032) & (M Doses) Table 134. Europe Polio Vaccine Sales Price by Application (2021-2026) & (USD/K Doses) Table 135. Europe Polio Vaccine Sales Price by Application (2027-2032) & (USD/K Doses) Table 136. Europe Polio Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Polio Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Polio Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Polio Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 140. Europe Polio Vaccine Sales by Country (2021-2026) & (M Doses) Table 141. Europe Polio Vaccine Sales by Country (2027-2032) & (M Doses) Table 142. Europe Polio Vaccine Sales Price by Country (2021-2026) & (USD/K Doses) Table 143. Europe Polio Vaccine Sales Price by Country (2027-2032) & (USD/K Doses) Table 144. Germany Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 145. France Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 146. U.K. Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 147. Italy Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 148. Russia Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 149. Spain Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 152. Sweden Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 153. Poland Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 154. China Polio Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 155. China Polio Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 156. China Polio Vaccine Sales by Type (2021-2026) & (M Doses) Table 157. China Polio Vaccine Sales by Type (2027-2032) & (M Doses) Table 158. China Polio Vaccine Sales Price by Type (2021-2026) & (USD/K Doses) Table 159. China Polio Vaccine Sales Price by Type (2027-2032) & (USD/K Doses) Table 160. China Polio Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 161. China Polio Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 162. China Polio Vaccine Sales by Application (2021-2026) & (M Doses) Table 163. China Polio Vaccine Sales by Application (2027-2032) & (M Doses) Table 164. China Polio Vaccine Sales Price by Application (2021-2026) & (USD/K Doses) Table 165. China Polio Vaccine Sales Price by Application (2027-2032) & (USD/K Doses) Table 166. Asia Polio Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Polio Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Polio Vaccine Sales by Type (2021-2026) & (M Doses) Table 169. Asia Polio Vaccine Sales by Type (2027-2032) & (M Doses) Table 170. Asia Polio Vaccine Sales Price by Type (2021-2026) & (USD/K Doses) Table 171. Asia Polio Vaccine Sales Price by Type (2027-2032) & (USD/K Doses) Table 172. Asia Polio Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Polio Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Polio Vaccine Sales by Application (2021-2026) & (M Doses) Table 175. Asia Polio Vaccine Sales by Application (2027-2032) & (M Doses) Table 176. Asia Polio Vaccine Sales Price by Application (2021-2026) & (USD/K Doses) Table 177. Asia Polio Vaccine Sales Price by Application (2027-2032) & (USD/K Doses) Table 178. Asia Polio Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Polio Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Polio Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Polio Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 182. Asia Polio Vaccine Sales by Country (2021-2026) & (M Doses) Table 183. Asia Polio Vaccine Sales by Country (2027-2032) & (M Doses) Table 184. Asia Polio Vaccine Sales Price by Country (2021-2026) & (USD/K Doses) Table 185. Asia Polio Vaccine Sales Price by Country (2027-2032) & (USD/K Doses) Table 186. Japan Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 187. South Korea Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 188. India Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Australia Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Polio Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Polio Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Polio Vaccine Sales by Type (2021-2026) & (M Doses) Table 195. SAMEA Polio Vaccine Sales by Type (2027-2032) & (M Doses) Table 196. SAMEA Polio Vaccine Sales Price by Type (2021-2026) & (USD/K Doses) Table 197. SAMEA Polio Vaccine Sales Price by Type (2027-2032) & (USD/K Doses) Table 198. SAMEA Polio Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Polio Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Polio Vaccine Sales by Application (2021-2026) & (M Doses) Table 201. SAMEA Polio Vaccine Sales by Application (2027-2032) & (M Doses) Table 202. SAMEA Polio Vaccine Sales Price by Application (2021-2026) & (USD/K Doses) Table 203. SAMEA Polio Vaccine Sales Price by Application (2027-2032) & (USD/K Doses) Table 204. SAMEA Polio Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Polio Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Polio Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Polio Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 208. SAMEA Polio Vaccine Sales by Country (2021-2026) & (M Doses) Table 209. SAMEA Polio Vaccine Sales by Country (2027-2032) & (M Doses) Table 210. SAMEA Polio Vaccine Sales Price by Country (2021-2026) & (USD/K Doses) Table 211. SAMEA Polio Vaccine Sales Price by Country (2027-2032) & (USD/K Doses) Table 212. Brazil Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Argentina Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Chile Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Colombia Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Peru Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Israel Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 219. UAE Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Turkey Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Iran Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Egypt Polio Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Polio Vaccine Distributors List Table 226. Polio Vaccine Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Polio Vaccine Image Figure 2. Global Polio Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polio Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Inactivated Polio Vaccine (IPV) Image Figure 5. Oral Polio Vaccine (OPV) Image Figure 6. Global Polio Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Polio Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Public Image Figure 9. Private Image Figure 10. Global Polio Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Polio Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Polio Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Polio Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Polio Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Polio Vaccine Sales (2021-2032) & (M Doses) Figure 16. Global Polio Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 17. Global Polio Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Polio Vaccine Sales YoY (2021-2032) & (M Doses) Figure 19. Europe Polio Vaccine Sales YoY (2021-2032) & (M Doses) Figure 20. China Polio Vaccine Sales YoY (2021-2032) & (M Doses) Figure 21. Asia (Excluding China) Polio Vaccine Sales YoY (2021-2032) & (M Doses) Figure 22. South America, Middle East and Africa Polio Vaccine Sales YoY (2021-2032) & (M Doses) Figure 23. Global Polio Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Polio Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Polio Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Polio Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Polio Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Polio Vaccine Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 30. Global Polio Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Polio Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Polio Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Polio Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Polio Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Polio Vaccine Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 36. Global Polio Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Polio Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Polio Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Polio Vaccine Sales Share by Type (2021-2032) Figure 40. North America Polio Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Polio Vaccine Sales Share by Application (2021-2032) Figure 42. North America Polio Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Polio Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Polio Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Polio Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Polio Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Polio Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Polio Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Polio Vaccine Sales Share by Country (2021-2032) Figure 50. China Polio Vaccine Revenue Share by Type (2021-2032) Figure 51. China Polio Vaccine Sales Share by Type (2021-2032) Figure 52. China Polio Vaccine Revenue Share by Application (2021-2032) Figure 53. China Polio Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Polio Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Polio Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Polio Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Polio Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Polio Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Polio Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Polio Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Polio Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Polio Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Polio Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Polio Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Polio Vaccine Sales Share by Country (2021-2032) Figure 66. Polio Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Polio Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Polio Vaccine (IPV)
  • Oral Polio Vaccine (OPV)
Applications
  • Public
  • Private
Companies covered
  • Sanofi
  • GSK
  • Bibcol
  • Serum Institute
  • Tiantan Biological
  • IMBCA
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Polio Vaccine Market by Type
  3. 1.2.1 Global Polio Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Inactivated Polio Vaccine (IPV)
  5. 1.2.3 Oral Polio Vaccine (OPV)
  6. 1.3 Polio Vaccine Market by Application
  7. 1.3.1 Global Polio Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Public
  9. 1.3.3 Private
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Polio Vaccine Market Dynamics
  1. 2.1 Polio Vaccine Industry Trends
  2. 2.2 Polio Vaccine Industry Drivers
  3. 2.3 Polio Vaccine Industry Opportunities and Challenges
  4. 2.4 Polio Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Polio Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Polio Vaccine Revenue by Region
  3. 3.2.1 Global Polio Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Polio Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Polio Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Polio Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Polio Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Polio Vaccine Sales by Region
  9. 3.4.1 Global Polio Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Polio Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Polio Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Polio Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Polio Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Polio Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Polio Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Polio Vaccine Sales by Manufacturers
  6. 4.2.1 Global Polio Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Polio Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Polio Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Polio Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Polio Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Polio Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Polio Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Polio Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Polio Vaccine Tier 1, Tier 2, and Tier 3
5 Polio Vaccine Market by Type
  1. 5.1 Global Polio Vaccine Revenue by Type
  2. 5.1.1 Global Polio Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Polio Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Polio Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Polio Vaccine Sales by Type
  6. 5.2.1 Global Polio Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Polio Vaccine Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Polio Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Polio Vaccine Price by Type
6 Polio Vaccine Market by Application
  1. 6.1 Global Polio Vaccine Revenue by Application
  2. 6.1.1 Global Polio Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Polio Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Polio Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Polio Vaccine Sales by Application
  6. 6.2.1 Global Polio Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Polio Vaccine Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Polio Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Polio Vaccine Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Polio Vaccine Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK Polio Vaccine Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 Bibcol
  14. 7.3.1 Bibcol Company Information
  15. 7.3.2 Bibcol Business Overview
  16. 7.3.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bibcol Polio Vaccine Product Portfolio
  18. 7.3.5 Bibcol Recent Developments
  19. 7.4 Serum Institute
  20. 7.4.1 Serum Institute Company Information
  21. 7.4.2 Serum Institute Business Overview
  22. 7.4.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Serum Institute Polio Vaccine Product Portfolio
  24. 7.4.5 Serum Institute Recent Developments
  25. 7.5 Tiantan Biological
  26. 7.5.1 Tiantan Biological Company Information
  27. 7.5.2 Tiantan Biological Business Overview
  28. 7.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Tiantan Biological Polio Vaccine Product Portfolio
  30. 7.5.5 Tiantan Biological Recent Developments
  31. 7.6 IMBCA
  32. 7.6.1 IMBCA Company Information
  33. 7.6.2 IMBCA Business Overview
  34. 7.6.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 IMBCA Polio Vaccine Product Portfolio
  36. 7.6.5 IMBCA Recent Developments
  37. 7.7 Panacea Biotec Ltd
  38. 7.7.1 Panacea Biotec Ltd Company Information
  39. 7.7.2 Panacea Biotec Ltd Business Overview
  40. 7.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
  42. 7.7.5 Panacea Biotec Ltd Recent Developments
  43. 7.8 Bio-Med
  44. 7.8.1 Bio-Med Company Information
  45. 7.8.2 Bio-Med Business Overview
  46. 7.8.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bio-Med Polio Vaccine Product Portfolio
  48. 7.8.5 Bio-Med Recent Developments
  49. 7.9 Halfkin Bio-Pharmaceuticals
  50. 7.9.1 Halfkin Bio-Pharmaceuticals Company Information
  51. 7.9.2 Halfkin Bio-Pharmaceuticals Business Overview
  52. 7.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
  54. 7.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Polio Vaccine Market Size by Type
  2. 8.1.1 North America Polio Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Polio Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Polio Vaccine Price by Type (2021-2032)
  5. 8.2 North America Polio Vaccine Market Size by Application
  6. 8.2.1 North America Polio Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Polio Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Polio Vaccine Price by Application (2021-2032)
  9. 8.3 North America Polio Vaccine Market Size by Country
  10. 8.3.1 North America Polio Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Polio Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Polio Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Polio Vaccine Market Size by Type
  2. 9.1.1 Europe Polio Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Polio Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Polio Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Polio Vaccine Market Size by Application
  6. 9.2.1 Europe Polio Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Polio Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Polio Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Polio Vaccine Market Size by Country
  10. 9.3.1 Europe Polio Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Polio Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Polio Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Polio Vaccine Market Size by Type
  2. 10.1.1 China Polio Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Polio Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Polio Vaccine Price by Type (2021-2032)
  5. 10.2 China Polio Vaccine Market Size by Application
  6. 10.2.1 China Polio Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Polio Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Polio Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Polio Vaccine Market Size by Type
  2. 11.1.1 Asia Polio Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Polio Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Polio Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Polio Vaccine Market Size by Application
  6. 11.2.1 Asia Polio Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Polio Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Polio Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Polio Vaccine Market Size by Country
  10. 11.3.1 Asia Polio Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Polio Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Polio Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Polio Vaccine Market Size by Type
  2. 12.1.1 SAMEA Polio Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Polio Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Polio Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Polio Vaccine Market Size by Application
  6. 12.2.1 SAMEA Polio Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Polio Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Polio Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Polio Vaccine Market Size by Country
  10. 12.3.1 SAMEA Polio Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Polio Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Polio Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Polio Vaccine Value Chain Analysis
  2. 13.1.1 Polio Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Polio Vaccine Production Mode & Process
  6. 13.2 Polio Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Polio Vaccine Distributors
  9. 13.2.3 Polio Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst